Updated: Radiopharma maker AdvanCell hauls in $315M for Pluvicto challenger – Endpoints News
Updated: Radiopharma maker AdvanCell hauls in $315M for Pluvicto challenger Endpoints News
New tool makes immune therapy more effective in prostate cancer – Medical Xpress
New tool makes immune therapy more effective in prostate cancer Medical Xpress
New tool makes immune therapy more effective in prostate cancer – Medical Xpress Read Post »
Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal – Fierce Biotech
Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal Fierce Biotech
Info on Risk for Prostate Cancer Spurs Decision-Making – Medscape
Info on Risk for Prostate Cancer Spurs Decision-Making Medscape
Info on Risk for Prostate Cancer Spurs Decision-Making – Medscape Read Post »
Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer – Medical Xpress
Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer Medical Xpress
A new generation of prostate cancer drugs is raising hope—here’s why – Futura, le média qui explore le monde
A new generation of prostate cancer drugs is raising hope—here’s why Futura, le média qui explore le monde
The surprising health benefit of being bald – New York Post
The surprising health benefit of being bald New York Post
The surprising health benefit of being bald – New York Post Read Post »
Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading – SciTechDaily
Researchers Uncover a Promising New Way To Stop Prostate Cancer From Spreading SciTechDaily
2nd PET scan changes treatment for nearly half of prostate cancer patients – Radiology Business
2nd PET scan changes treatment for nearly half of prostate cancer patients Radiology Business
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients – Medical Xpress
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients Medical Xpress